144
Views
0
CrossRef citations to date
0
Altmetric
Studies in humans

Lignan intake and risk of cardiovascular disease and type 2 diabetes: a meta-analysis of prospective cohort studies

, , &
Pages 501-509 | Received 08 Feb 2023, Accepted 29 May 2023, Published online: 06 Jun 2023

References

  • Adriouch S, Lampure A, Nechba A, Baudry J, Assmann K, Kesse-Guyot E, Hercberg S, Scalbert A, Touvier M, Fezeu LK. 2018. Prospective association between total and specific dietary polyphenol intakes and cardiovascular disease risk in the nutrinet-Sante French cohort. Nutrients. 10(11):1587.
  • Esfandiar Z, Hosseini-Esfahani F, Mirmiran P, Yuzbashian E, Azizi F. 2020. The association of dietary polyphenol intake with the risk of type 2 diabetes: tehran lipid and glucose study. Diabetes Metab Syndr Obes. 13:1643–1652.
  • Frankenfeld CL. 2017. Cardiometabolic risk and gut microbial phytoestrogen metabolite phenotypes. Mol Nutr Food Res. 61(1):1500900.
  • Fukumitsu S, Aida K, Shimizu H, Toyoda K. 2010. Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men. Nutr Res. 30(7):441–446.
  • Goya L, Roman RS, de Pascual-Teresa S. 2022. Polyphenols’ effect on cerebrovascular health. Curr Med Chem. 29(6):1029–1044.
  • Greenland S. 1987. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 9:1–30.
  • Greenland S, Longnecker MP. 1992. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 135(11):1301–1309.
  • Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Galvano F, Giovannucci EL. 2017. Dietary flavonoid and lignan intake and mortality in prospective cohort studies: systematic review and dose-response meta-analysis. Am J Epidemiol. 185(12):1304–1316.
  • Grosso G, Stepaniak U, Micek A, Kozela M, Stefler D, Bobak M, Pajak A. 2017. Dietary polyphenol intake and risk of type 2 diabetes in the polish arm of the health, alcohol and psychosocial factors in Eastern Europe (HAPIEE) study. Br J Nutr. 118(1):60–68.
  • Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wahala K, Deyama T, Nishibe S, Adlercreutz H. 2001. In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem. 49(7):3178–3186.
  • Hu Y, Li Y, Sampson L, Wang M, Manson JE, Rimm E, Sun Q. 2021. Lignan intake and risk of coronary heart disease. J Am Coll Cardiol. 78(7):666–678.
  • Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. 2020. Epidemiology of type 2 diabetes - Global burden of disease and forecasted trends. J Epidemiol Glob Health. 10(1):107–111.
  • Landete JM, Arques J, Medina M, Gaya P, de Las Rivas B, Munoz R. 2016. Bioactivation of phytoestrogens: intestinal bacteria and health. Crit Rev Food Sci Nutr. 56(11):1826–1843.
  • Laouali N, Berrandou T, J AR, Shah S, El Fatouhi D, Romana Mancini F, Boutron-Ruault MC, Fagherazzi G. 2020. Profiles of polyphenol intake and type 2 diabetes risk in 60,586 women followed for 20 years: results from the E3N cohort study. Nutrients. 12(7):1934.
  • Larsson SC, Orsini N, Wolk A. 2011. Dietary potassium intake and risk of stroke: a dose-response meta-analysis of prospective studies. Stroke. 42(10):2746–2750.
  • Li D, Luo F, Guo T, Han S, Wang H, Lin Q. 2022. Targeting NF-kappaB pathway by dietary lignans in inflammation: expanding roles of gut microbiota and metabolites. Crit Rev Food Sci Nutr. 24:1–17.
  • Mendelsohn ME, Karas RH. 1999. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 340(23):1801–1811.
  • Milder IE, Feskens EJ, Arts IC, Bueno-de-Mesquita HB, Hollman PC, Kromhout D. 2006. Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the Zutphen elderly study. Am J Clin Nutr. 84(2):400–405.
  • Orsini N, Bellocco R, Greenland S. 2006. Generalized least squares for trend estimation of summarized dose-response data. The Stata Journal. 6(1):40–57.
  • Pan A, Sun J, Chen Y, Ye X, Li H, Yu Z, Wang Y, Gu W, Zhang X, Chen X, et al. 2007. Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One. 2(11):e1148.
  • Pellegrini N, Valtuena S, Ardigo D, Brighenti F, Franzini L, Del Rio D, Scazzina F, Piatti PM, Zavaroni I. 2010. Intake of the plant lignans matairesinol, secoisolariciresinol, pinoresinol, and lariciresinol in relation to vascular inflammation and endothelial dysfunction in middle age-elderly men and post-menopausal women living in Northern Italy. Nutr Metab Cardiovasc Dis. 20(1):64–71.
  • Peterson J, Dwyer J, Adlercreutz H, Scalbert A, Jacques P, McCullough ML. 2010. Dietary lignans: physiology and potential for cardiovascular disease risk reduction. Nutr Rev. 68(10):571–603.
  • Pietrofesa R, Turowski J, Tyagi S, Dukes F, Arguiri E, Busch TM, Gallagher-Colombo SM, Solomides CC, Cengel KA, Christofidou-Solomidou M. 2013. Radiation mitigating properties of the lignan component in flaxseed. BMC Cancer. 13:179.
  • Qian F, Liu G, Hu FB, Bhupathiraju SN, Sun Q. 2019. Association between plant-based dietary patterns and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA Intern Med. 179(10):1335–1344.
  • Quek J, Lim G, Lim WH, Ng CH, So WZ, Toh J, Pan XH, Chin YH, Muthiah MD, Chan SP, et al. 2021. The association of plant-based diet with cardiovascular disease and mortality: a meta-analysis and systematic review of prospect cohort studies. Front Cardiovasc Med. 8:756810.
  • Rhee Y, Brunt A. 2011. Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design. Nutr J. 10:44.
  • Rienks J, Barbaresko J, Nothlings U. 2017. Association of polyphenol biomarkers with cardiovascular disease and mortality risk: a systematic review and meta-analysis of observational studies. Nutrients. 9(4):415.
  • Rienks J, Barbaresko J, Oluwagbemigun K, Schmid M, Nothlings U. 2018. Polyphenol exposure and risk of type 2 diabetes: dose-response meta-analyses and systematic review of prospective cohort studies. Am J Clin Nutr. 108(1):49–61.
  • Senizza A, Rocchetti G, Mosele JI, Patrone V, Callegari ML, Morelli L, Lucini L. 2020. Lignans and gut microbiota: an interplay revealing potential health implications. molecules. 25(23):5709.
  • Stang A. 2010. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 25(9):603–605.
  • Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 283(15):2008–2012.
  • Sun Q, Wedick NM, Pan A, Townsend MK, Cassidy A, Franke AA, Rimm EB, Hu FB, van Dam RM. 2014. Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women. Diabetes Care. 37(5):1287–1295.
  • Talaei M, Pan A. 2015. Role of phytoestrogens in prevention and management of type 2 diabetes. World J Diabetes. 6(2):271–283.
  • Tresserra-Rimbau A, Guasch-Ferre M, Salas-Salvado G, Toledo E, Corella D, Castaner O, Guo X, Gomez-Gracia E, Lapetra J, Aros F, et al. 2016. Intake of total polyphenols and some classes of polyphenols is inversely associated with diabetes in elderly people at high cardiovascular disease risk. J Nutr. 146(4):767–777.
  • Tresserra-Rimbau A, Rimm EB, Medina-Remon A, Martinez-Gonzalez MA, de la Torre R, Corella D, Salas-Salvado J, Gomez-Gracia E, Lapetra J, Aros F, et al. 2014. Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study. Nutr Metab Cardiovasc Dis. 24(6):639–647.
  • van der Schouw YT, Kreijkamp-Kaspers S, Peeters PH, Keinan-Boker L, Rimm EB, Grobbee DE. 2005. Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation. 111(4):465–471.
  • Vazquez-Ruiz Z, Toledo E, Vitelli-Storelli F, Goni L, de la OV, Bes-Rastrollo M, Martinez-Gonzalez MA. 2022. Effect of dietary phenolic compounds on incidence of cardiovascular disease in the SUN Project; 10 years of follow-up. Antioxidants . 11(4):783.
  • Velentzis LS, Cantwell MM, Cardwell C, Keshtgar MR, Leathem AJ, Woodside JV. 2009. Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies. Br J Cancer. 100(9):1492–1498.
  • Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, et al. 2021. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 143(8):e254–e743.
  • World Health Organization. 2021. Cardiovascular diseases. Available at: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1. (accessed on November 20, 2022)
  • Xia M, Zhong Y, Peng Y, Qian C. 2022. Olive oil consumption and risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Front Nutr. 9:1041203.
  • Zamora-Ros R, Forouhi NG, Sharp SJ, Gonzalez CA, Buijsse B, Guevara M, van der Schouw YT, Amiano P, Boeing H, Bredsdorff L, et al. 2013. The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study. Diabetes Care. 36(12):3961–3970.
  • Zamora-Ros R, Jimenez C, Cleries R, Agudo A, Sanchez MJ, Sanchez-Cantalejo E, Molina-Montes E, Navarro C, Chirlaque MD, Maria Huerta J, et al. 2013. Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology. 24(5):726–733.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.